Clinical Trials Directory

Trials / Conditions / Diagnostic

Diagnostic

14 registered clinical trials studyying Diagnostic — 5 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationArtificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology
NCT07454941
Cancer Institute and Hospital, Chinese Academy of Medical Sciences—
Not Yet RecruitingOptical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.
NCT07406022
Centre Hospitalier Régional Metz-Thionville—
Not Yet RecruitingAI-Assisted Saliva Diagnostics Using an Electrochemical Sensor Platform for Periodontitis Detection (SALIENCE)
NCT07254039
Ostergotland County Council, Sweden—
Not Yet RecruitingFemale Genital Schistosomiasis in Migrant Women: A Pilot Study
NCT06828536
Assistance Publique - Hôpitaux de ParisN/A
CompletedRole of Inflammatory Markers in Sepsis
NCT06111963
National Cancer Institute, Egypt—
RecruitingA Study on Diagnosis and Treatment Strategies for Atlantoaxial Dislocation
NCT06233539
Peking University Third Hospital—
CompletedDetecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry
NCT05384470
Mclean Hospital—
UnknownStudy of the Prevalence of Iron Deficiency in Patients With Scheduled Major Surgery (CARENFER PBM)
NCT04800042
VIFORFRANCEN/A
CompletedPARamedical Abnormalties Detection of Traumatic Bone Lesion of the extremitIeS
NCT05076188
Poitiers University Hospital—
UnknownSchistosomiasis Diagnosis Using a CAA Antigen Test
NCT03779347
Centre de Recherche Médicale de LambarénéPhase 3
CompletedSarcopenia Cut-points and Functionality in Older Adults
NCT03832608
University of Valencia—
UnknownSysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral
NCT03495570
University College, London—
CompletedEvaluation of the Performance of a Rapid Pregnancy Diagnostic Test.
NCT03250884
Rennes University Hospital—
TerminatedTopical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia
NCT01746940
Lannett Company, Inc.Phase 3